Plasma SMOC2 Predicts Prognosis in Patients with Heart Failure: A Prospective Cohort

References

• Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118(17):3272–3287. PMID: 35150240. doi:10.1093/cvr/cvac013
   PubMed Web of Science ®Google Scholar
• Baman JR, Ahmad FS. Heart Failure. JAMA. 2020;324(10):1015. PMID: 32749448. doi:10.1001/jama.2020.13310
   PubMedGoogle Scholar
• Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Biomarkers for the diagnosis and management of heart failure. Heart Fail Rev. 2022;27(2):625–643. PMID: 33852110; PMCID: PMC8898236. doi:10.1007/s10741-021-10105-w
   PubMed Web of Science ®Google Scholar
• Vannahme C, Gösling S, Paulsson M, Maurer P, Hartmann U. Characterization of SMOC-2, a modular extracellular calcium-binding protein. Biochem J. 2003;373(Pt 3):805–814.
   PubMedGoogle Scholar
• Rocnik EF, Liu P, Sato K, Walsh K, Vaziri C. The novel SPARC family member SMOC-2 potentiates angiogenic growth factor activity. J Biol Chem. 2006;281(32):22855–22864. PMID: 16774925. doi:10.1074/jbc.M513463200
   PubMed Web of Science ®Google Scholar
• Morkmued S, Clauss F, Schuhbaur B, et al. Deficiency of the SMOC2 matricellular protein impairs bone healing and produces age-dependent bone loss. Sci Rep. 2020;10(1):14817. PMID: 32908163; PMCID: PMC7481257. doi:10.1038/s41598-020-71749-6
   PubMed Web of Science ®Google Scholar
• Wilk JB, Herbert A, Shoemaker CM, Gottlieb DJ, Karamohamed S. Secreted modular calcium-binding protein 2 haplotypes are associated with pulmonary function. Am J Respir Crit Care Med. 2007;175(6):554–560. PMID: 17204727; PMCID: PMC1899283. doi:10.1164/rccm.200601-110OC
   PubMed Web of Science ®Google Scholar
• Rui H, Zhao F, Yuhua L, Hong J. Suppression of SMOC2 alleviates myocardial fibrosis via the ILK/p38 pathway. Front Cardiovasc Med. 2023;9:951704. PMID: 36935650; PMCID: PMC10017443. doi:10.3389/fcvm.2022.951704
   PubMed Web of Science ®Google Scholar
• Bakaeen FG, Gaudino M, Whitman G, et al. 2021: the American Association for Thoracic Surgery Expert Consensus Document: coronary artery bypass grafting in patients with ischemic cardiomyopathy and heart failure. J Thorac Cardiovasc Surg. 2021;162(3):829–850.e1. doi:10.1016/j.jtcvs.2021.04.052
   PubMed Web of Science ®Google Scholar
• Wang Y, Yang H, Su X, et al. TGF-β1/SMOC2/AKT and ERK axis regulates proliferation, migration, and fibroblast to myofibroblast transformation in lung fibroblast, contributing with the asthma progression. Hereditas. 2021;158(1):47. PMID: 34876240; PMCID: PMC8653533. doi:10.1186/s41065-021-00213-w
   PubMed Web of Science ®Google Scholar
• Liu D, Li R, Xu S, et al. SMOC2 promotes aggressive behavior of fibroblast-like synoviocytes in rheumatoid arthritis through transcriptional and post-transcriptional regulating MYO1C. Cell Death Dis. 2022;13(12):1035. PMID: 36513634; PMCID: PMC9747908. doi:10.1038/s41419-022-05479-0
   PubMed Web of Science ®Google Scholar
• Feng D, Gao P, Henley N, et al. SMOC2 promotes an epithelial-mesenchymal transition and a pro-metastatic phenotype in epithelial cells of renal cell carcinoma origin. Cell Death Dis. 2022;13(7):639. PMID: 35869056; PMCID: PMC9307531. doi:10.1038/s41419-022-05059-2
   PubMed Web of Science ®Google Scholar
• Kim HS, Choi JH, Lee JY, et al. Downregulation of SMOC2 expression in papillary thyroid carcinoma and its prognostic significance. Sci Rep. 2020;10(1):4853. PMID: 32184420; PMCID: PMC7078233. doi:10.1038/s41598-020-61828-z
   PubMed Web of Science ®Google Scholar
• Li D, Lin H, Li L. Multiple feature selection strategies identified novel cardiac gene expression signature for heart failure. Front Physiol. 2020;11:604241. PMID: 33304275; PMCID: PMC7693561. doi:10.3389/fphys.2020.604241
   PubMed Web of Science ®Google Scholar
• Zhou L, Peng F, Li J, Gong H. Exploring novel biomarkers in dilated cardiomyopathy-induced heart failure by integrated analysis and in vitro experiments. Exp Ther Med. 2023;26(1):325. PMID: 37346398; PMCID: PMC10280324. doi:10.3892/etm.2023.12024
   PubMed Web of Science ®Google Scholar
• Laugier L, Frade AF, Ferreira FM, et al. Whole-Genome Cardiac DNA methylation fingerprint and gene expression analysis provide new insights in the pathogenesis of chronic Chagas disease cardiomyopathy. Clin Infect Dis. 2017;65:1103–1111.
   PubMed Web of Science ®Google Scholar
• Jang BG, Kim HS, Bae JM, Kim WH, Kim HU, Kang GH. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers. Sci Rep. 2020;10(1):14591. PMID: 32884102; PMCID: PMC7471277. doi:10.1038/s41598-020-71643-1
   PubMed Web of Science ®Google Scholar
• Schmidt IM, Colona MR, Kestenbaum BR, et al. Kidney Precision Medicine Project (KPMP). Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium-derived factor are promising non-invasive biomarkers of kidney fibrosis. Kidney Int. 2021;100(3):672–683. PMID: 34051265; PMCID: PMC8384690. doi:10.1016/j.kint.2021.04.037
   PubMed Web of Science ®Google Scholar
• Luo L, Wang CC, Song XP, et al. Suppression of SMOC2 reduces bleomycin (BLM)-induced pulmonary fibrosis by inhibition of TGF-β1/SMADs pathway. Biomed Pharmacother. 2018;105:841–847. PMID: 30021376. doi:10.1016/j.biopha.2018.03.058
   PubMed Web of Science ®Google Scholar
• Gerarduzzi C, Kumar RK, Trivedi P, et al. Silencing SMOC2 ameliorates kidney fibrosis by inhibiting fibroblast to myofibroblast transformation. JCI Insight. 2017;2(8):e90299. PMID: 28422762; PMCID: PMC5396522. doi:10.1172/jci.insight.90299
   PubMed Web of Science ®Google Scholar
• González A, Schelbert EB, Díez J, Butler J. Myocardial interstitial fibrosis in heart failure: biological and translational perspectives. J Am Coll Cardiol. 2018;71(15):1696–1706. PMID: 29650126. doi:10.1016/j.jacc.2018.02.021
   PubMed Web of Science ®Google Scholar
• Zhang W, Man Y, Chen Z. microRNA-148a in Exosomes derived from bone marrow mesenchymal stem cells alleviates cardiomyocyte apoptosis in atrial fibrillation by inhibiting SMOC2. Mol Biotechnol. 2022;64(10):1076–1087. PMID: 35397056. doi:10.1007/s12033-022-00487-z
   PubMed Web of Science ®Google Scholar
• Zhang B, Mao S, Liu X, et al. MiR-125b inhibits cardiomyocyte apoptosis by targeting BAK1 in heart failure. Mol Med. 2021;27(1):72. PMID: 34238204; PMCID: PMC8268255. doi:10.1186/s10020-021-00328-w
   PubMed Web of Science ®Google Scholar
• Zhang S, Cai B, Li Z, et al. Fibroblastic SMOC2 suppresses mechanical nociception by inhibiting coupled activation of primary sensory neurons. J Neurosci. 2022;42(20):4069–4086. PMID: 35437277; PMCID: PMC9121839. doi:10.1523/JNEUROSCI.2132-21.2022
   PubMed Web of Science ®Google Scholar
• Xin C, Lei J, Wang Q, et al. Therapeutic silencing of SMOC2 prevents kidney function loss in mouse model of chronic kidney disease. iScience. 2021;24(10):103193. PMID: 34703992; PMCID: PMC8524153.SMOC2. doi:10.1016/j.isci.2021.103193
   PubMed Web of Science ®Google Scholar
• Adamo L, Rocha-Resende C, Prabhu SD, Mann DL. Reappraising the role of inflammation in heart failure. Nat Rev Cardiol. 2020;17(5):269–285. PMID: 31969688. doi:10.1038/s41569-019-0315-x
   PubMed Web of Science ®Google Scholar